Sponsor or institution
Clinical trials and research at Novadip Biosciences
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Novadip Biosciences that are recruiting, at sites in 5 countries (most in Luxembourg (1), Belgium (1), France (1)). By phase: Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
NVD003 treatment for congenital pseudarthrosis of the tibia
This will try NVD003, an autologous stem-cell–based bone graft, in children with congenital pseudarthrosis of the tibia to see if it leads to better bone healing at 12 months than standard iliac crest bone graft.
-
Long-term safety evaluation of NVDX3 treatment
This study is testing the long-term safety of the NVDX3 treatment in patients who have already received it, by checking in with them every year for 10 years to see if they experience any problems.
Quick answers
How many clinical trials run by Novadip Biosciences are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Luxembourg (1 trial), Belgium (1 trial), France (1 trial), Spain (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.